Cargando…
Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy
BACKGROUND: Natalizumab is a monoclonal antibody approved for the treatment of patients with relapsing-remitting multiple sclerosis. According to the current clinical recommendations, its use during pregnancy should be carefully evaluated only in women with highly active disease who plan a pregnancy...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987111/ https://www.ncbi.nlm.nih.gov/pubmed/33757559 http://dx.doi.org/10.1186/s13052-021-01025-4 |